Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1200
http://purl.obolibrary.org/obo/NCIT_C1200
|
|---|---|
| Preferred Name | Pegaspargase |
| Definitions |
A complex of polyethylene glycol conjugated with L-asparaginase. Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting these cells of asparagine and blocking protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle. The agent also induces apoptosis in tumor cells. Pegylation decreases the enzyme's antigenicity. Asparagine is critical to protein synthesis in leukemic cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A complex of polyethylene glycol conjugated with L-asparaginase. Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting these cells of asparagine and blocking protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle. The agent also induces apoptosis in tumor cells. Pegylation decreases the enzyme's antigenicity. Asparagine is critical to protein synthesis in leukemic cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. (NCI04) |
|---|---|
| prefLabel | Pegaspargase
|
| label | Pegaspargase
|
| PDQ_Closed_Trial_Search_ID | 40312
|
| code | C1200
|
| prefixIRI | NCIT:C1200
|
| in_subset |
See more
See less
|
| Display_Name | Pegaspargase
|
| Preferred_Name | Pegaspargase
|
| FDA_UNII_Code | 7D96IR0PPM
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | Pegaspargase
|
| CAS_Registry | 130167-69-0
|
| NSC Number |
624239
644954
|
| NCI_Drug_Dictionary_ID | 40312
|
| Legacy Concept Name | Pegaspargase
|
| type | |
| ALT_DEFINITION | A drug used to treat acute lymphoblastic leukemia (ALL). It is a form of the drug asparaginase that is linked to a substance called PEG, which makes the drug stay in the body longer. Asparaginase is an enzyme that breaks down the amino acid asparagine and may block the growth of tumor cells that need asparagine to grow. It is a type of protein synthesis inhibitor.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 40312
|
| Accepted_Therapeutic_Use_For | Acute lymphoblastic leukemia
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C0071568
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |